Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.26% | 177.68 | 0.7% | $1347.08m | |
| MRK | Merck & Co., Inc. | 0.44% | 93.05 | 0.7% | $1217.31m | |
| PFE | Pfizer Inc. | 0.48% | 51.89 | 0.9% | $1100.48m | |
| LLY | Eli Lilly & Co. | 0.25% | 328.00 | 1.1% | $1028.73m | |
| BMY | Bristol-Myers Squibb Co. | 0.38% | 76.25 | 1.0% | $995.29m | |
| ABBV | AbbVie, Inc. | -0.97% | 152.43 | 1.9% | $950.87m | |
| AZN | AstraZeneca Plc | 0.40% | 65.77 | 1.0% | $472.83m | |
| SGEN | Seagen Inc. | -0.64% | 175.64 | 5.7% | $323.98m | |
| GSK | GSK Plc | -0.75% | 42.98 | 0.2% | $270.38m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.20% | 75.00 | 0.0% | $198.88m | |
| HZNP | Horizon Therapeutics Plc | -1.33% | 81.66 | 5.4% | $171.77m | |
| NVS | Novartis AG | -1.12% | 83.34 | 0.2% | $170.34m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.07% | 150.63 | 8.1% | $150.21m | |
| MRTX | Mirati Therapeutics, Inc. | -1.45% | 70.92 | 1.6% | $148.63m | |
| NVO | Novo Nordisk A/S | -0.82% | 110.33 | 0.1% | $147.15m |
Company Profile
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.